Nanjing Sinolife United Company Limited (3332.HK)
HKD 0.58
(1.75%)
HKD 0.58
(1.75%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 563.95 Million CNY | 105.19% |
| 2022 | 274.85 Million CNY | 8.93% |
| 2021 | 252.32 Million CNY | -14.91% |
| 2020 | 296.52 Million CNY | -8.09% |
| 2019 | 322.61 Million CNY | -28.81% |
| 2018 | 453.19 Million CNY | -4.08% |
| 2017 | 472.49 Million CNY | 1.34% |
| 2016 | 466.24 Million CNY | 17.42% |
| 2015 | 397.06 Million CNY | 57.28% |
| 2014 | 252.44 Million CNY | 29.64% |
| 2013 | 194.73 Million CNY | 29.5% |
| 2012 | 150.37 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 185.09 Million CNY | 7.29% |
| 2024 Q2 | 185.09 Million CNY | 0.0% |
| 2023 Q4 | 172.51 Million CNY | 0.0% |
| 2023 FY | 563.95 Million CNY | 105.19% |
| 2023 Q1 | 109.46 Million CNY | 43.95% |
| 2023 Q2 | 109.46 Million CNY | 0.0% |
| 2023 Q3 | 172.51 Million CNY | 57.6% |
| 2022 FY | 274.85 Million CNY | 8.93% |
| 2022 Q3 | 76.04 Million CNY | 23.89% |
| 2022 Q2 | 61.38 Million CNY | 0.0% |
| 2022 Q1 | 61.38 Million CNY | -4.55% |
| 2022 Q4 | 76.04 Million CNY | 0.0% |
| 2021 Q4 | 64.3 Million CNY | 0.0% |
| 2021 FY | 252.32 Million CNY | -14.91% |
| 2021 Q3 | 64.3 Million CNY | 3.96% |
| 2021 Q2 | 61.85 Million CNY | 0.0% |
| 2021 Q1 | 61.85 Million CNY | -23.74% |
| 2020 Q3 | 81.11 Million CNY | 20.79% |
| 2020 Q4 | 81.11 Million CNY | 0.0% |
| 2020 Q2 | 67.15 Million CNY | 0.0% |
| 2020 Q1 | 67.15 Million CNY | -21.2% |
| 2020 FY | 296.52 Million CNY | -8.09% |
| 2019 Q4 | 85.21 Million CNY | 0.0% |
| 2019 FY | 322.61 Million CNY | -28.81% |
| 2019 Q1 | 76.08 Million CNY | -34.37% |
| 2019 Q2 | 76.08 Million CNY | 0.0% |
| 2019 Q3 | 85.21 Million CNY | 12.0% |
| 2018 Q4 | 115.93 Million CNY | 0.0% |
| 2018 Q3 | 115.93 Million CNY | 4.77% |
| 2018 FY | 453.19 Million CNY | -4.08% |
| 2018 Q2 | 110.66 Million CNY | 0.0% |
| 2018 Q1 | 110.66 Million CNY | -2.6% |
| 2017 Q2 | 122.62 Million CNY | 0.0% |
| 2017 FY | 472.49 Million CNY | 1.34% |
| 2017 Q1 | 122.62 Million CNY | -12.23% |
| 2017 Q4 | 113.61 Million CNY | 0.0% |
| 2017 Q3 | 113.61 Million CNY | -7.35% |
| 2016 FY | 466.24 Million CNY | 17.42% |
| 2016 Q2 | 93.4 Million CNY | 0.0% |
| 2016 Q1 | 93.4 Million CNY | -24.68% |
| 2016 Q4 | 139.71 Million CNY | 0.0% |
| 2016 Q3 | 139.71 Million CNY | 49.58% |
| 2015 Q4 | 124.01 Million CNY | 0.0% |
| 2015 Q2 | 74.51 Million CNY | 0.0% |
| 2015 FY | 397.06 Million CNY | 57.28% |
| 2015 Q1 | 74.51 Million CNY | -4.75% |
| 2015 Q3 | 124.01 Million CNY | 66.43% |
| 2014 Q1 | 47.99 Million CNY | -11.76% |
| 2014 Q4 | 78.23 Million CNY | 0.0% |
| 2014 Q2 | 47.99 Million CNY | 0.0% |
| 2014 FY | 252.44 Million CNY | 29.64% |
| 2014 Q3 | 78.23 Million CNY | 63.02% |
| 2013 Q3 | 54.38 Million CNY | 26.53% |
| 2013 Q4 | 54.38 Million CNY | 0.0% |
| 2013 FY | 194.73 Million CNY | 29.5% |
| 2013 Q1 | 42.98 Million CNY | 0.48% |
| 2013 Q2 | 42.98 Million CNY | 0.0% |
| 2012 Q3 | 42.77 Million CNY | 13.79% |
| 2012 FY | 150.37 Million CNY | 0.0% |
| 2012 Q2 | 37.59 Million CNY | 0.0% |
| 2012 Q1 | 37.59 Million CNY | 0.0% |
| 2012 Q4 | 42.77 Million CNY | 0.0% |
| 2011 Q4 | 37.59 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 336.01 Million HKD | -67.837% |
| Innovative Pharmaceutical Biotech Limited | 6.59 Million HKD | -8453.906% |
| China Overseas Nuoxin International Holdings Limited | 180.99 Million HKD | -211.588% |
| Prosperous Future Holdings Limited | 470.33 Million HKD | -19.907% |
| Huasheng International Holding Limited | 565.9 Million HKD | 0.344% |
| Fourace Industries Group Holdings Limited | 268.02 Million HKD | -110.414% |
| Evergreen Products Group Limited | 979.24 Million HKD | 42.409% |
| EC Healthcare | 4.21 Billion HKD | 86.608% |
| Ming Fai International Holdings Limited | 2.06 Billion HKD | 72.72% |
| Blue Moon Group Holdings Limited | 7.32 Billion HKD | 92.299% |
| SuperRobotics Holdings Limited | 15.08 Million HKD | -3639.533% |
| Takbo Group Holdings Limited | 215.59 Million HKD | -161.587% |
| Hyfusin Group Holdings Limited | 866.25 Million HKD | 34.897% |